A detailed history of Payden & Rygel Investment Group transactions in Danaher Corp stock. As of the latest transaction made, Payden & Rygel Investment Group holds 1,000 shares of DHR stock, worth $235,840. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$235,840
Previous $250,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 08, 2024

SELL
$224.58 - $256.19 $11.8 Million - $13.5 Million
-52,580 Reduced 98.13%
1,000 $250,000
Q1 2024

May 13, 2024

SELL
$224.58 - $256.19 $11.8 Million - $13.5 Million
-52,580 Reduced 98.13%
1,000 $250,000
Q3 2023

Oct 08, 2024

BUY
$233.08 - $265.59 $12.3 Million - $14 Million
52,580 Added 5258.0%
53,580 $11.8 Million
Q3 2023

Nov 08, 2023

BUY
$233.08 - $265.59 $12.5 Million - $14.2 Million
53,580 New
53,580 $11.8 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Payden & Rygel Investment Group Portfolio

Follow Payden & Rygel Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel Investment Group with notifications on news.